Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 2

Results: 12

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4 T cells.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 193, doi. 10.1007/s00262-015-1791-4

By:

Ohno, Yosuke;
Kitamura, Hidemitsu;
Takahashi, Norihiko;
Ohtake, Junya;
Kaneumi, Shun;
Sumida, Kentaro;
Homma, Shigenori;
Kawamura, Hideki;
Minagawa, Nozomi;
Shibasaki, Susumu;
Taketomi, Akinobu

Publication type:

Article

Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 141, doi. 10.1007/s00262-015-1780-7

By:

Lee, Ban;
Lee, Sang;
Son, Jun;
Jang, Dong;
Chung, Kwang;
Lee, Yoon;
Paik, Woo;
Ryu, Ji;
Kim, Yong-Tae

Publication type:

Article

Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 223, doi. 10.1007/s00262-015-1789-y

By:

Ayari, Cherifa;
Besançon, Marjorie;
Bergeron, Alain;
LaRue, Hélène;
Bussières, Vanessa;
Fradet, Yves

Publication type:

Article

Acknowledgement.

Published in:: Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 243, doi. 10.1007/s00262-016-1794-9
Publication type:: Article

A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 151, doi. 10.1007/s00262-015-1781-6

By:

Noguchi, Masanori;
Moriya, Fukuko;
Koga, Noriko;
Matsueda, Satoko;
Sasada, Tetsuro;
Yamada, Akira;
Kakuma, Tatsuyuki;
Itoh, Kyogo

Publication type:

Article

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 161, doi. 10.1007/s00262-015-1782-5

By:

Mandruzzato, Susanna;
Brandau, Sven;
Britten, Cedrik;
Bronte, Vincenzo;
Damuzzo, Vera;
Gouttefangeas, Cécile;
Maurer, Dominik;
Ottensmeier, Christian;
Burg, Sjoerd;
Welters, Marij;
Walter, Steffen

Publication type:

Article

Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 205, doi. 10.1007/s00262-015-1784-3

By:

Saraswathula, Anirudh;
Reap, Elizabeth;
Choi, Bryan;
Schmittling, Robert;
Norberg, Pamela;
Sayour, Elias;
Herndon, James;
Healy, Patrick;
Congdon, Kendra;
Archer, Gerald;
Sanchez-Perez, Luis;
Sampson, John

Publication type:

Article

Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 181, doi. 10.1007/s00262-015-1786-1

By:

Dielmann, Anastasia;
Letsch, Anne;
Nonnenmacher, Anika;
Miller, Kurt;
Keilholz, Ulrich;
Busse, Antonia

Publication type:

Article

8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015-May 20-22, Vancouver, Canada.

Published in:

2016

By:

Boudreau, Jeanette;
Wouters, Maartje;
Krawczyk, Connie

Publication type:

Report

Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 171, doi. 10.1007/s00262-015-1787-0

By:

Campa, Michael;
Moody, M.;
Zhang, Ruijun;
Liao, Hua-Xin;
Gottlin, Elizabeth;
Patz, Edward

Publication type:

Article

Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 127, doi. 10.1007/s00262-015-1772-7

By:

Smilowitz, Henry;
Micca, Peggy;
Sasso, Daniel;
Wu, Qian;
Dyment, Nathanial;
Xue, Crystal;
Kuo, Lynn

Publication type:

Article

Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 213, doi. 10.1007/s00262-015-1788-z

By:

Chawla, Sharad;
Warren, Timothy;
Wockner, Leesa;
Lambie, Duncan;
Brown, Ian;
Martin, Thomas;
Khanna, Rajiv;
Leggatt, Graham;
Panizza, Benedict

Publication type:

Article